- Home
- CLDT vs RIGL Comparison
CLDT vs RIGL Comparison
Compare CLDT & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDT | RIGL |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | 16 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.5M | 564.7M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | CLDT | RIGL |
|---|---|---|
| Price | $13.53 | $38.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $11.00 | ★ $45.67 |
| AVG Volume (30 Days) | ★ 475.4K | 350.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.13% | N/A |
| EPS Growth | N/A | ★ 1867.68 |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $294,282,000.00 |
| Revenue This Year | $2.94 | N/A |
| Revenue Next Year | N/A | $12.75 |
| P/E Ratio | $610.21 | ★ $87.93 |
| Revenue Growth | N/A | ★ 64.15 |
| 52 Week Low | $6.08 | $18.24 |
| 52 Week High | $13.64 | $52.24 |
Technical Indicators
Market Signals| Indicator | CLDT | RIGL |
|---|---|---|
| Relative Strength Index (RSI) | 74.38 | 78.92 |
| Support Level | $6.41 | $33.39 |
| Resistance Level | N/A | $44.85 |
| Average True Range (ATR) | 0.41 | 1.50 |
| MACD | 0.00 | 0.65 |
| Stochastic Oscillator | 94.39 | 95.00 |
Price Performance
Historical ComparisonAbout CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.